VP Research & Development
Stephen Chang, PhD, Vice President for Research and Development at NYSCF, leads R&D projects and has oversight of regulations and policies related to business units, partnerships with industry and other institutions.
Prior to joining NYSCF, Dr. Chang served as Chief Scientific Officer of Stemgent upon the company’s founding in 2008. He was previously the CEO of Multicell Technologies and continues as a director of this company. Dr. Chang is president of CURES, a coalition dedicated to ensuring the safety, research, and development of innovative life-saving medications. He is also a board member of Histogen, Inc., a privately held company in regenerative medicine.
Dr. Chang received his PhD in biological chemistry, molecular biology, and biochemistry from the University of California, Irvine.